anti-HSP antibody product blog
Tags: Antibody; Polyclonal Antibody; HSP; anti-HSP antibody;
The HSP n/a (Catalog #MBS417105) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Anti-HSP Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s HSP can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC).WB: 1:500~1:1000
IHC: 1:50~100. Researchers should empirically determine the suitability of the HSP n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The HSP n/a product has the following accession number(s) (GI #30090017) (NCBI Accession #NP_839948.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Storage Buffer: phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Immunogen: The antiserum was produced against synthesized phosphopeptide derived from human HSP27 around the phosphorylation site of serine 78 (A-L-SP-R-Q). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HSP are readily searchable from our website. Different antibodies against the same target such as HSP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.